Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunrest LifescienceNSE:SUNREST 41 PB Ratio is 0.82 as of Jul. 23, 2026, which is 47% below its 10-year median of 1.56. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Sunrest Lifescience ranks better than 85.34% on this metric.
Sunrest Lifescience Ltd stock PB Ratio (=0.82) is close to 3-year low of 0.8.
The historical rank and industry rank for Sunrest Lifescience's PB Ratio or its related term are showing as below:
NSE:SUNREST'
s PB Ratio Range Over the Past 10 Years
Min: 0.8 Med: 1.56 Max: 10.52
Current: 0.82
During the past 7 years, Sunrest Lifescience's highest PB Ratio was 10.52. The lowest was 0.80. And the median was 1.56.
NSE:SUNREST's PB Ratio is ranked better than 85.34% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 1.99
vs NSE:SUNREST: 0.82
During the past 12 months, Sunrest Lifescience's average Book Value Per Share Growth Rate was 25.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 87.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 141.60% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Sunrest Lifescience was 263.70% per year. The lowest was 87.20% per year. And the median was 168.25% per year.
Back to Basics: PB Ratio
Sunrest Lifescience (NSE:SUNREST) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sunrest Lifescience PB Ratio Related Terms
Sunrest Lifescience PB Ratio Historical Data
* Premium members only.
The historical data trend for Sunrest Lifescience's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunrest Lifescience PB Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunrest Lifescience PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sunrest Lifescience's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sunrest Lifescience (NSE:SUNREST) has a PB Ratio of 0.82 as of Jul. 23, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sunrest Lifescience and its competitors. This is 47% below median its historical median of 1.56. Over the past decade, Sunrest Lifescience's PB Ratio has ranged from 0.80 to 10.52. According to the industry distribution chart, Sunrest Lifescience ranks #89 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 14.7%.
Is Sunrest Lifescience's PB Ratio too high?
Sunrest Lifescience's current PB Ratio of 0.82 is 47% below median its 10-year median of 1.56. Over the past 10 years, this metric has ranged from a low of 0.80 to a high of 10.52. The Healthcare Providers & Services industry median PB Ratio is 1.99. Sunrest Lifescience's value of 0.82 is 58.8% below this industry median. Based on the distribution chart, Sunrest Lifescience ranks #89 out of 607 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #89 out of 607 companies for PB Ratio. This places Sunrest Lifescience in the top 15% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.99. Sunrest Lifescience's value of 0.82 is 58.8% below this benchmark. Historically, Sunrest Lifescience's own PB Ratio has ranged from 0.80 to 10.52 over the past decade. While the company's 10-year median is 1.56 vs. the industry median of 1.99, Sunrest Lifescience has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current PB Ratio of 0.82 is 58.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current PB Ratio is 0.82, which is 47% below median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current PB Ratio of 0.82. The current PB Ratio is 0.82, which is 47% below median its 10-year median of 1.56 and 58.8% below the Healthcare Providers & Services industry median of 1.99. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current PB Ratio is 0.82 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score
Get the complete analysis for NSE:SUNREST
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNREST has been successfully added to your 
